Daewoong Pharmaceutical Leads AI-Driven Digital Health Devices

Daewoong Pharmaceutical

Daewoong Pharmaceutical Pioneers with AI Digital Medical Devices

Daewoong Pharmaceutical, a leader in digital healthcare, uses AI technology to safeguard employee health. They’re setting trends in the digital medical device space, focusing on early detection and management of major health issues.

Introduction to Daewoong’s Initiative

Daewoong started the year by implementing in-house health check-ups using digital devices. This move helps employees catch health issues early. Here’s a snapshot of what they did:

  • Conducted tests for employees aged 40 and above.
  • Used AI devices for a comprehensive health assessment.
  • Designed a system for prevention and personalized advice.

The Digital Healthcare Frontier

Digital healthcare merges medical care with information and communication technology (ICT). Its benefits include:

  • No location constraints.
  • Customized healthcare solutions.
  • Continuous growth in market size.

Daewoong’s Employee Health Checks

For health tests at their Seoul headquarters, Daewoong used advanced tech for employees and staff, focusing on common health problems such as:

Major Tests Conducted

  1. Retinal and Eye Health:

    • Used WISKY, an AI solution, for diagnosing major eye diseases like diabetic retinopathy, macular degeneration, and glaucoma.
    • Further examination with the Optina Genesis camera for detailed retinal scans.
  2. Blood Sugar Levels:

    • Continuous glucose monitoring for detecting irregular blood sugar levels without needing blood samples.
  3. Muscle Health:

  • AI-based device measured signs of sarcopenia, a condition where muscle mass depletes, reducing strength and ability over time.

Understanding Health Devices

These devices help you understand and manage your health better.

  • AI Vision Solutions: Diagnose multiple eye conditions in one go.
  • Glucose Monitors: Analyze sugar levels using a sensor on your arm.
  • Muscle Diagnostics: Detect muscle loss early, crucial for maintaining overall strength as you age.

Insights on Sarcopenia in Adults

Sarcopenia becomes more prevalent with age. Key points to note are:

  • Muscle mass reduces from the age of 50 at approximately 1% per year.
  • The condition accelerates after 65.
  • By 2022, the prevalence among those 65 and older was nearly 8%.

Daewoong’s Vision Moving Forward

CEO Chang-jae Lee emphasized Daewoong’s leading role in the digital healthcare market. They commit to enhancing employee health through innovative use of medical devices.

Future Plans

  • Predict and manage diseases using data-based solutions.
  • Continue integrating diagnosis, treatment, and aftercare in healthcare ecosystems.
  • Drive innovation and growth by emphasizing data analysis and health management solutions.

Closing Thoughts

By optimized use of AI-driven technology, Daewoong aims to lead in both employee welfare and the digital healthcare market. Focus on precision, real-time data, and personal insights marks a shift towards more efficient healthcare management.

Daewoong’s strategy demonstrates how modern companies can align healthcare innovation with workplace wellbeing, paving the way for not only industry leaders but also setting a robust example for future advancements.

Key Takeaways

  • Importance of early health detection using AI.
  • Management and prevention of chronic issues like sarcopenia.
  • Daewoong’s integrated approach to healthcare management, from prediction to post-care.

Feel empowered to manage your health with the aid of AI. Tracking and proactive measures can offer better control over personal health journeys.

Table of Contents:

  1. Introduction to Daewoong’s Initiative
    • Overview of Daewoong Pharmaceutical’s focus on employee health through digital devices
    • Summary of in-house health check-up implementation
  2. The Digital Healthcare Frontier
    • Definition and scope of digital healthcare
    • Benefits of integrating ICT with healthcare solutions
  3. Daewoong’s Employee Health Checks
    • Details on the health tests conducted at the Seoul headquarters
    • Focus on major health problems targeted
  4. Major Tests Conducted
    • Retinal and Eye Health:
      • Use of WISKY AI solution for diagnosing eye diseases
      • Explanation of further examination with the Optina Genesis camera
    • Blood Sugar Levels:
      • Continuous glucose monitoring techniques
    • Muscle Health:
      • AI-based diagnostics for sarcopenia detection and its significance
  5. Understanding Health Devices
    • Overview of the AI-driven health devices employed
    • Explanation of the different health technologies and their benefits
  6. Insights on Sarcopenia in Adults
    • Prevalence and effects of sarcopenia with age
    • Key statistics on muscle mass reduction
  7. Daewoong’s Vision Moving Forward
    • CEO Chang-jae Lee’s perspective on the company’s role in digital healthcare
    • Future plans for integrating data-based solutions and enhancing health management
  8. Closing Thoughts
    • Summary of Daewoong’s strategy in harmonizing health innovation with employee welfare
    • Reflection on the importance of early detection and proactive health management
  9. Key Takeaways
    • Summary of the role of AI in early health detection and chronic issue management
    • Emphasis on Daewoong’s integrated healthcare approach from prediction to post-care
Scroll to Top